UNH vs VRTV: Which Is the Better Buy?

Side-by-side comparison of UnitedHealth Group Incorporated and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-17.
UnitedHealth Group Incorporated · Healthcare
$423.38
+45.0% upside to fair value
Grade B High Quality
VS
Veritiv Corporation · Industrials
$169.99
-43.3% upside to fair value
Grade D
QuantHub Verdict
UNH has more upside to fair value (+45.0%). VRTV trades at a lower forward P/E (7.1x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric UNH VRTV
Current Price $423.38 $169.99
Fair Value Estimate $613.90 $96.38
Upside to Fair Value +45.0% -43.3%
Market Cap $384.5B $2.3B
Forward P/E 27.2x 7.1x
EV / EBITDA 13.8x 5.4x
Price / Sales 0.8x 0.3x
Price / FCF 19.6x 10.0x
Revenue Growth YoY +0.4% -19.0%
Gross Margin 18.8% 22.7%
Operating Margin 4.2% 5.9%
Return on Equity 12.4% 48.6%
Dividend Yield 0% 0%
FCF Yield 5.12% 9.99%
Analyst Consensus Strong Buy Hold
Investment Thesis
UNH — UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
VRTV — Veritiv Corporation
Veritiv Corporation operates as a distributor primarily in packaging, facility solutions, and print markets, with a business quality characterized by scale and network density rather than proprietary products or pricing power. The company has undergone significant transformation under CEO Salvatore A. Abbate, including a take-private transaction by Clayton, Dubilier & Rice in 2023 and a strategic…
Accumulation Zones
Metric UNH VRTV
Zone Low $460.42 $72.28
Zone High $521.81 $81.92
In Buy Zone? Yes No
← UNH Research    VRTV Research →    All Research